Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Asia Cannabis Corp. (C:ASIA)

Business Focus: Alternative Medicine

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for ASIA within the last 6 months
See all filings within the past 6 months

Company News

Sep 08, 2020 13:10 ET
IIROC Trade Resumption - ASIA
VANCOUVER, BC, Sept. 8, 2020 /CNW/ - Trading resumes in:
Read full article
Sep 08, 2020 12:35 ET
Asia Green Biotechnology Corp. Expands Technology License Agreement with Pathway Rx Inc. by Entering Corresponding Agreement with PNW Biosciences Inc.
CALGARY, AB / ACCESSWIRE / September 8, 2020 / Asia Green Biotechnology Corp. ("AGB" or the "Company") (CSE:ASIA) is pleased to announce that it has entered an agreement with Pathway Rx Inc. ("Pathway Rx") and PNW Biosciences Inc. ("PNW") in which the three companies have determined to act collaboratively to affect the clinical development and commercialization of the Cannabis sativa varieties for prevention and for treatment of COVID-19 and other infectious diseases to which Pathway Rx Inc. owns the rights. Both AGB and PNW have previously
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Nov 15, 202033,10133,059
Oct 31, 2020420
Oct 15, 2020420
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Asia Green Biotechnology Corp., formerly, Asia Cannabis Corp. is a Canada-based early-stage international agri-technology company. The Company centered on the planting, growing, and harvesting of valuable strains of hemp and related crops in commercial quantities in South Asia. The Company's technology secures exposure to and capacities in the hemp and related sectors through horticultural, scientific, genetic and genomic. The Company's products include food, fuel, fiber and foundation.

See business summary



Search (past week) for $ASIA.CA

  • No tweets found